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Understanding how undifferentiated cells per­
ceive and integrate signals that affect their de­
velopmental program is an important task. 
Specifically, T helper responses are orchestrated 
by differentiated cells originating from precur­
sors that acquire their final phenotype under 
the instruction of professional APCs. Our ef­
forts have focused on observing the synapses 
formed by T helper precursors (Thps), as op­
posed to differentiated Th cells, in an attempt 
to reproduce the molecular events at the initia­
tion of adaptive immune responses rather than 
their reactivation. As extensively demonstrated 
(1), only Thps have the potential to translate 
early signaling events in the adaptive immune 
responses into permanent epigenetic changes 
that define their cytokine secretion pattern, and 
therefore their function. Activation and differ­
entiation of Thps require signaling through 
three major sets of receptors: the antigen rec­
ognition receptor (TCR), accessory or costim­
ulatory receptors (e.g., CD28), and certain key 
cytokine (and perhaps chemokine) receptors. 
TCR and costimulatory receptors are necessary 
for activation, but not sufficient for full Th cell 
differentiation, whereas cytokine instruction is 
essential to achieve full in vivo Th skewing (1, 
2). TCR and CD28 coreceptors are redistrib­
uted during activation and organized in a mo­
lecular complex at the interface between the T 
cell and APC, which is designated the immuno­
logical synapse (IS) (3–5).
Mature Th1 and Th2 subsets display differ­
ences in IS morphology (6, 7). Although assembly 
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The antigen recognition interface formed by T helper precursors (Thps) and antigen-pre-
senting cells (APCs), called the immunological synapse (IS), includes receptors and signaling 
molecules necessary for Thp activation and differentiation. We have recently shown that 
recruitment of the interferon- receptor (IFNGR) into the IS correlates with the capacity 
of Thps to differentiate into Th1 effector cells, an event regulated by signaling through the 
functionally opposing receptor to interleukin-4 (IL4R). Here, we show that, similar to IFN- 
ligation, TCR stimuli induce the translocation of signal transducer and activator of tran-
scription 1 (STAT1) to IFNGR1-rich regions of the membrane. Unexpectedly, STAT1 is 
preferentially expressed, is constitutively serine (727) phosphorylated in Thp, and is re-
cruited to the IS and the nucleus upon TCR signaling. IL4R engagement controls this pro-
cess by interfering with both STAT1 recruitment and nuclear translocation. We also show 
that in cells with deficient Th1 or constitutive Th2 differentiation, the IL4R is recruited to 
the IS. This observation suggest that the IL4R is retained outside the IS, similar to the 
exclusion of IFNGR from the IS during IL4R signaling. This study provides new mechanistic 
cues for the regulation of lineage commitment by mutual immobilization of functionally 
antagonistic membrane receptors.
© 2009 Maldonado et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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In this study, we have identified STAT1 as one of the mo­
lecular components of the IS. We show that STAT1 is recruited 
to the IS upon TCR signaling, similar to its recruitment to the 
IFNGR upon ligand occupancy. Unexpectedly, we observed 
that STAT1 is preferentially expressed and serine (727) phos­
phorylated (pS727­STAT1) in resting Thps, a posttranslational 
modification known to be required for successful IFNGR signal­
ing (21–23) and STAT1 transcription. The constitutive phos­
phorylation of STAT1 in the Thp may explain the preferential 
mobilization of  Th1­like signaling components during T cell ac­
tivation. Remarkably, pS727­STAT1 molecules are required for 
optimal Th1 differentiation and recruited to the IS, and they 
translocate to the nucleus upon TCR signaling. Concomitant 
with IFNGR dynamics, STAT1 and pS727­STAT1 are blocked 
in the presence of IL­4. Finally, we demonstrate that in mirroring 
IFNGR exclusion from the IS by IL­4 signaling and Th2 differ­
entiation, the IL4R is excluded from the IS and polarizes with 
the TCR only in cells with constitutive Th2 differentiation.
RESULTS
STAT1 and IFNGR1 are corecruited to the IS
We  have  suggested  that  an  alternative  pro­Th1  pathway  in 
which the corecruitment of IFNGR1 and TCR to the IS could 
elicit IFN­–like signaling and tip the T helper balance toward 
Th1 differentiation (8). Although corecruitment does not re­
quire IFN­ or STAT1, mice deficient for STAT1 (stat1/) 
are severely impaired in their ability to mount Th1 responses 
(24–27). These observations led us to question whether STAT1 
might be mobilized and activated as a functional consequence of 
the cross talk between IFNGR and TCR signaling pathways.
Thps isolated from 4–6­wk­old OTII transgenic mice were 
sorted using magnetic bead negative separation, followed by 
FACS sorting of CD4+CD62LhighCD44lowCD25 T cells from 
LNs and spleen. DCs were purified using a CD11c magnetic 
bead positive selection and loaded or not with 1 µM of OVA 
peptide (323–339 ISQAVHAAHAEINEAGR). After elimi­
nating debris by a density gradient and several washes, both cell 
populations were mixed, spun down to increase their inter­
action, fixed, and stained for the markers shown in Fig. 1 a. For 
all the molecules analyzed in this study, negative control stain­
ings were prepared using genetically deficient Thps (from   
ifngr1/, stat1/, and il4ra/ mice; unpublished data). Im­
aging of these cells using confocal microscopy revealed that 
100 of the 113 Thp­DC clusters (89%) in 2 independent ex­
periments displayed accumulations of  TCR toward the inter­
face in the presence of OVA­loaded DCs, but not unpulsed, 
DCs (unpublished data). Strikingly, STAT1 was recruited to 
the T cell–DC interface and colocalized with the TCR similar 
to the IFNGR, as previously reported (8).
To circumvent signal noise originating from DCs (that ex­
press variable levels of IFNGR and STAT1; unpublished data), 
as well as any variability in the DC maturation status, subset 
composition, antigen load, and in situ cytokine secretion, T cells 
were activated by TCR cross­linking using monoclonal anti­
bodies. In our hands, the cross­linking of  TCR molecules on 
Thps recapitulates with high fidelity the multifocal aggregation 
of  membrane  clusters  and  the  IS  clearly  optimizes  signal 
transduction downstream of the TCR, leading to mature Th 
cell activation, the mechanisms by which such assembly con­
tributes to the acquisition of helper function (the secretion of 
cytokines) remain poorly understood. However, recent stud­
ies by our group and others have highlighted the importance 
of receptor clustering and establishment of membrane asym­
metry in the acquisition of specific effector (Th1, Th2, and 
Th17) (8–11) or memory phenotypes (12, 13). Importantly, 
Chang et al. have shown that in addition to signaling optimi­
zation, synapse formation dictates the segregation of receptors 
by asymmetrical cell division of precursor cells, and therefore 
the function of the daughter cells (12). Further, Yeh et al. have 
shown that this functional segregation may be perpetuated by 
the class I MHC–restricted T cell–associated molecule, an 
immunoglobulin superfamily transmembrane protein that 
coordinates Scrib­initiated polarity (10).
In vivo Th1 differentiation depends on signaling through 
the IFN­ receptor (IFNGR), the IL­12 receptor (IL12R), 
and their downstream transcription factors signal transducer 
and activator of transcription 1 (STAT1) and STAT4, respec­
tively (1, 14). Mice lacking any of these factors fail to generate 
type 1 immune responses. IL12R is not expressed by Thps, but 
is crucial for Th1 maintenance and survival, whereas IFNGR 
is expressed by these cells and initiates a positive feedback loop 
of  Th1 differentiation. Thus, IFN­ signaling initiates the Th1 
differentiation program and IL­12 perpetuates it (14). Simi­
larly, mature Th2 cells arise after occupancy of the IL4R by its 
ligand and subsequent activation of STAT6 (15, 16). Both the 
IFN­ and IL4Rs undergo trans­ and cis­tyrosine phosphory­
lation of their cytosolic domains by receptor­associated Janus 
kinases (JAKs). These activated JAK molecules phosphorylate 
STAT1 (on tyrosine 701 and serine 727) (17) or STAT6, in­
ducing their dimerization and translocation to the nucleus to 
initiate transcriptional regulation of target genes (18).
Among these target genes are the key transcription factors 
T­bet and GATA3 required for the execution of the Th1 and 
Th2 differentiation programs, respectively (1, 16). However, 
these transcription factors and the cytokines that induce them are 
nearly absent during the activation of  Thps. The other cellular 
component of the IS, the DC, does not secrete detectable levels 
of IFN­ or IL­4 (19, 20). Hence, neither the source of early 
cytokine signaling nor how the Thp perceives the initial stimuli 
that initiate lineage commitment are well understood.
We addressed this issue by showing that only the pro­Th1 
cytokine receptor IFNGR and not the pro­Th2 IL4R is re­
cruited to the IS upon TCR activation. This corecruitment 
correlates with Th1 maturation (8). Further, we demonstrated 
that IL4R signaling leads to the blockade of IFNGR1 recruit­
ment to the IS (and Th2 differentiation). This exclusion of IF­
NGR1 from the IS also provides a biophysical explanation for 
the well accepted dominance of  Th2 over Th1 differentiation 
in a cytokine milieu where both IFN­ and IL­4 are present 
(14). These observations indicate that localization of receptors 
influences how T cells acquire effector functions during anti­
gen recognition.JEM VOL. 206, April 13, 2009 
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Fig. 1 b shows a typical example of  Thp activation by cross­
linking, where the TCR and IFNGR1 are uniformly distrib­
uted at 0 min and rearranged in discrete regions of the surface   
30 min after activation. Here again, STAT1 was recruited to 
TCR­ and IFNGR1­rich regions of the membrane.
We quantified these images with an improved version of 
the “linearization” of the cell surface method (8). In our previ­
ous study, linearization of the cell surface was achieved by 
drawing regions around the single middle z axis optical section 
(z section) to include the plasma membrane and the adjacent 
cytoplasm of every cell to (line)scan their content within flu­
orescent markers (Fig. S1). An example of this traditional 
of receptors observed in DC­Thp synapses observed in our ex­
periments, while offering a clean system for quantification pur­
poses. The prototypical concentric organization in supramolecular 
activation complexes is rarely observed in our Thp­DC co­cul­
tures. Accordingly, Brossard et al. (28) have also described that 
the synapses formed by naive T cells and DCs are different from 
those formed by mature Th cells and B cells. These and other 
studies suggest that when antigen presentation is abundant (like 
in our cultures), synapses formed by Thps are multifocal and 
very dynamic, with both cellular components being highly mo­
tile in complete media, collagen matrixes (unpublished data), 
and in vivo (28–30).
Figure 1.  Corecruitment of TCR, IFNGR1, and STAT1 to the IS. (a) Thps were purified from the LNs of young animals by magnetic negative separa-
tion using antibody-coupled microbeads and the MACS system, followed by FACS sorting of CD4+CD62highCD25-CD44low cells. These Thps from OTII trans-
genic mice were mixed with OVA peptide-pulsed DCs, fixed, stained, and imaged for the markers indicated. Shown are pictures of two independent 
experiments. (b) Sorted Thps were stained and activated by TCR cross-linking with a combination of anti-TCR (APC) and goat anti-hamster antibodies 
(Alexa-647). When indicated, 20ng/ml of recombinant mouse IFN- or IL-4 was added to the culture. Cells were fixed and stained with monoclonal anti-
bodies directed against the indicated molecules. For every condition indicated, left images represent the middle optical z section of the cell, and the right 
image represents the maximum projection for all the z sections of that cell. Images in the figures were processed to exclude out-of-focus pixels with the 
nearest neighbors deconvolution method. Shown are pictures of four independent experiments. Bars, 3 µm.880 CYTOKINE RECEPTOR INCLUSION IN THE IMMUNOLOGICAL SYNAPSE | Maldonado et al.
method is shown in Fig. 2 a (bottom), where the pixel inten­
sities of the given markers (y axis) were plotted according to 
their position in the region (105 positions at the middle plane; 
x axis). Before activation (0 min), the distribution of the markers 
was uniform and the majority of positions scored low pixel 
intensities. After activation (30 min), the corecruitment of these 
molecules is translated by the single­peak appearance of the 
slopes and the condensation of the fluorescence in discrete ar­
eas of the histogram. To obtain a quantitative measure of the 
relationship between the distributions of the different mole­
cules, their correlation coefficient was calculated (; see Ma­
terials and methods for a detailed description). The usage of  
normalizes the variability in expression (or pixel counts) of the 
different molecules by yielding values independent from scale 
and origin ranging from 1 to 1 (1 ≤  ≤ 1). Thereby all z sec­
tions, cells, and experiments can be cross­compared. A value of 
 = 1 reflects inverse correlation;  = 0 reflects no correla­
tion; and  = 1 reflects complete correlation. In Fig. 2 a,  was 
calculated for the distributions of STAT1/IFNGR1, IFNGR1/
TCR, and STAT1/TCR before and after activation (0.33, 0.37, 
0.32–0.78, 0.80, and 0.89). This traditional linearization analysis 
corresponded only to the middle z section of the cell (plane z = 
20 of 40), thereby excluding large portions of the membrane. 
Hence, we improved the quantification method to analyze the 
totality of the cell surface, 40 optical z sections (0.5 µm). 41–
105 positions were scanned per z section. The bottom and top 
z sections are smaller and contain fewer scanned positions, 
whereas the middle z sections are larger. The graphs in Fig. 2 a 
(top) represent surface scanning of the entire cell in a concat­
enated view where every 41–105 positions in the x axis rep­
resents one z section. Every z section displays a very similar 
pattern to the z = 20 plane, with uniform low pixel counts for 
TCR, IFNGR1, and STAT1 before activation and binary dis­
tributions after activation, where most positions scored either 
high or null values of pixel intensities, thus reflecting the po­
larized nature of the surface of these cells. Notably, the cyto­
plasm of  Thps is extremely small and our analysis most likely 
includes the majority of it.
This improved linearization analysis multiplied the amount 
of information available from a single cell by 200­fold and al­
lowed us to measure  for all cell planes (Fig. S2). Fig. 2 b shows 
the correlation values based on “whole­cell linearization” analy­
sis from four individual experiments accumulating 89–92 cells 
and 10–40 z sections per cell. Values of  are shown as corre­
lation plots, where every point represents one z section (n = 
1,840–2,670). In this familiar dot plot–like representation, it is 
clear that before activation all molecules are independently   
dispersed as indicated by low correlations in the STAT1/IF­
NGR1 (y axis) and TCR/IFNGR1 (x axis) distributions. Only 
11 and 6% of cell z sections scored  ≥ 0.8, respectively. A 
score of the correlation coefficient >0.8 is generally considered 
strong, whereas a correlation <0.5 is generally described as 
weak. For  ≥ 0.8, 2 = 0.64 (square of the coefficient), which 
means that 64% of the total variation in the y axis can be ex­
plained by the linear relationship between x and y. The asso­
ciation between STAT1 and the TCR before activation is 
Figure 2.  Quantification of  TCR, IFNGR1, and STAT1 corecruit-
ment. (a) Linearization of the cell membrane. Schematic representation of 
the redistribution of membrane receptors on the surface of  Thps before 
and after activation (top). Regions around the cell surface were drawn 
and scanned using the Metamorph software to obtain the mean pixel 
intensities of the membrane-bound markers analyzed with their x, y coor-
dinates in all z planes of every cell. Top histograms depict the totality of z 
sections of one cell where pixel intensities (y axis) were plotted according 
to their position in a concatenated fashion, with one z section per every 
40–100 positions in the x axis. Bottom histograms represent the middle z 
section of the cell (z = 20) where pixel intensities were plotted according 
to their position in the region (x axis, 100 positions scanned). STAT1, red; 
IFNGR1, green; and TCR, purple. (b) Corecruitment analysis by whole cell 
linearization of the cell surface and correlation plots. In these correlation 
plots where every dot represents the value of correlation between the 
distributions of STAT1 and IFNGR1 (left) or STAT1 and TCR (right) in the y 
axis and TCR and IFNGR1 on the x axis in one z section of a particular cell. 
This analysis results from combination of four independent experiments.JEM VOL. 206, April 13, 2009 
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presence of small numbers of central memory T cells (TCM) 
among the CD4+CD62LhighCD25 T cells. Further, serine 
phosphorylation has been demonstrated to be very sensitive to 
cell stress and manipulation. These considerations raised the 
possibility that the increased levels of pS727­STAT1 observed 
in Thps may correspond to contaminating TCM or an artifact 
resulting from extensive manipulation caused by magnetic and 
FACS sorting. To circumvent these problems and confirm pre­
ferential STAT1 and pS727­STAT1 expression by Thps, we 
performed intracellular stainings of STAT1 (unpublished data) 
and pS727­STAT1 on freshly isolated LN cells. These cells were 
washed once with cold PBS and immediately fixed with PFA 
and methanol. These procedures were done at 4°C in 7 min. 
Fig. 3 b shows the gating strategy for Thps and the expression 
of pS727­STAT1 in Thps from both WT and STAT1­defi­
cient mice, confirming that the population of CD4+CD25C
D44lowCD62Lhigh Thps expresses pS727­STAT1. Therefore, T 
cell maturation does not induce sustained STAT1 activation, 
but rather is accompanied by a selective loss in STAT1, pS727­
STAT1, and IFN­–inducible pY701­STAT1 expression, sug­
gesting that only Thps, but not thymocytes or activated Th cells, 
have the capacity to respond to STAT1­activating stimuli.
To study in more detail the origin and regulation of preex­
isting expression of pS727­STAT1 in Thps, we compared the 
status of STAT1 in WT, IFNGR1, or IFNAR1­deficient cells. 
Fig. 3 c shows one representative experiment of three where 
protein extracts from wt, ifnar1/, or ifngr1/ Thp display com­
parable STAT1 content. This pattern is not altered by IFN­ 
(Fig. S4). Again, pS727­STAT1 was observed before activa­
tion and independent of IFN signaling as purified IFNGR1­ 
or IFNAR1­deficient Thps contain levels of this phosphoform 
equivalent to wt. The variability noted in IFN­–inducible 
pS272­STAT1 may correspond to the use of different mouse 
control strains B6 (ifngr1/) and BALB/c (ifnar1/). Finally, 
TCR signaling did not affect STAT1 phosphoform expression. 
Hence, Thp activation controls STAT1 through its physical 
mobilization to the IS and not through controlling its tyrosine or 
serine phosphorylation status.
Role of IFNGR1, STAT1, and pS727-STAT1  
in Th1 differentiation in vitro
The importance of IFN­ and STAT1 signaling in cellular   
immune responses has been highlighted in multiple in vivo 
systems (17, 34). However, it has been suggested that Th1 diff­
erentiation can occur in the absence of IFN­ stimulus (35). 
Isolating the contribution of IFNGR signaling in Th differen­
tiation during in vivo responses can be challenging, as antigen 
clearance requires activation of multiple components of both 
adaptive and innate immune responses that are also dependent 
on IFNGR signaling (B cells, CD8 T cells, macrophages, etc). 
In vitro studies using purified naive T cells have clearly estab­
lished that IFN­ alone, independent of IL­12 or IL­18, can 
induce full Th1 differentiation (36, 37). To evaluate the con­
tribution of the IFNGR1, STAT1, and pS727­STAT1 to Thp 
differentiation in the absence of exogenous cytokines, we iso­
lated Thps from IFNGR1­ or STAT1­deficient animals and 
minimal, with only 9% of cell sections with  ≥ 0.8 (bottom 
left). After 30 min, Thps have capped their TCR, IFNGR1, 
and STAT1 molecules, as reflected by the “double­positive” 
aspect of the correlation plots where 40, 42, and 46% of z 
sections scored  ≥ 0.8 for STAT1/IFNGR1, STAT1/TCR, 
and TCR/IFNGR1 distributions, respectively. In the pres­
ence of IL­4, this corecruitment is inhibited, and  values re­
semble those obtained before activation (3–9% of cell sections 
have  ≥ 0.8). When averaged on a per cell basis, these correla­
tion plots retain the previously described properties (Fig. S2). 
This new type of analysis and representation provides a quanti­
tative and statistically rigorous examination of the distribution 
of receptors in the whole surface of a cell both on an individual 
and population scale. These results confirm with high confi­
dence the recruitment of IFNGR to the IS and reveal STAT1 
as a new member of this macromolecular complex.
Phosphorylation status of STAT1 during T cell development, 
activation, and differentiation
We showed in a previous work (8), as well as in this study, that 
IFNGR and STAT1 can be mobilized during T cell activa­
tion in the absence of IFN signaling, suggesting that this pro­
Th1 stimulus can be triggered by TCR engagement alone. 
To test whether STAT1 expression and phosphorylation at 
the two known major sites, tyrosine 701 (pY701­STAT1) and 
serine 727 (pS727­STAT1), varied during T cell development 
and differentiation, we compared double­positive thymocytes 
(DPs), Thps, Th0, Th1, and Th2 cells for the expression of these 
molecules. DPs were purified by FACS sorting of CD4+CD8+­
CD11cCD11bDX5DTCRB220CD19  thymic  cells. 
CD4+CD62LhighCD25  Thps  were  purified  using  magnetic 
negative separation complemented by cytofluorometric sorting 
(>99% pure). Thps were differentiated in vitro using standard 
protocols to induce Th0, Th1, and Th2 differentiation (see Ma­
terials and methods). Fig. 3 a shows a representative experiment 
where the levels of expression of STAT1 vary significantly at 
different stages of  T cell development and differentiation (see 
quantification in Fig. S3). Thps express markedly higher levels 
of STAT1 than thymic DP precursors or Th subsets (between 
1.2­ and 170­fold higher). Interestingly, DPs and Th2 cells ex­
pressed very low levels of STAT1 (174­ and 67­fold less than 
Thps, respectively) and only prolonged exposures of the blots 
allowed their visualization (bottom), whereas Th0 and Th1 
cells display 30–50% reductions. To our surprise, pS727­STAT1 
expression in Thps was detectable and preceded any activation, 
whereas its presence was barely detectable in DP and Th cells. As 
negative and positive controls, we used extracts from stat1/ or 
wt Thps incubated in the presence of IFN­ or not (Fig. 2 a and 
Fig. S4). Although IFN­ only variably increased pS727­STAT1 
levels, it was however, required for STAT1 tyrosine phosphory­
lation, as expected. The disparity in the capacity of IFN­ to in­
duce pY701­STAT1 at different T cell activation stages has been 
observed before and can be explained by the down­regulation of 
IFNGR expression after T helper differentiation or the increased 
expression of SOCS inhibitors (31–33). Our sorting strate­
gies for the aforementioned experiments cannot exclude the   882 CYTOKINE RECEPTOR INCLUSION IN THE IMMUNOLOGICAL SYNAPSE | Maldonado et al.
NGR1­deficient and STAT1­S727A mutant Thps could differ­
entiate into IFN­ producers under these conditions (Fig. 4 a). 
Remarkably,  in  STAT1­deficient  animals  the  secretion  of 
IFN­ was completely abolished, showing the impact of this 
signaling pathway in Th differentiation. Concurrently, a two­
fold increase in IL­4–producing T cells from Ifngr1/ LNs 
was observed when compared with the WT control, whereas 
mice bearing a serine 727 to alanine point mutation of STAT1 
(STAT1­S727A) that abolishes STAT1 serine phosphorylation 
at this site (38). Sorted CD4+CD62LhighCD25CD44low Thps 
were activated in vitro using monoclonal antibodies against 
CD3 and CD28 and assessed for their cytokine secretion poten­
tial. Between 60 and 73% of wt T cells secreted robust levels of 
IFN­ in vitro after activation. In contrast, only 25–36% of IF­
Figure 3.  Phosphorylation status of STAT1 during T cell development differentiation and activation. (a) STAT1 and phospho-STAT1 analysis on 
DP thymocytes, Thp, and Th cells. Cells were isolated from the thymus, spleen, and LNs of young animals. Thps were purified by magnetic bead negative 
selection and flow cytometry and activated using Th0 (0, with IL-2), Th1 (1, with IFN-, IL-2, and anti-IL4), and Th2 (2, with IL-4 and anti-IFN-) condi-
tions. In parallel, DPs were sorted by flow cytometry as in Materials and methods. All cell types (except for DPs) were left untreated (–) or incubated with 
IFN- (+) for 30 min before cell lysis. Cells lysates were analyzed by Western blot, and two different time exposures of the blots are shown. The sizes of 
the corresponding fragments are indicated in parenthesis. Quantification was achieved by densitometric analysis of the blots. The values shown corre-
spond to the percentage relative to the highest density normalized to each individual HSP90 control (see Materials and methods). Shown are blots repre-
sentative of two independent experiments. (b) Intracellular staining of pS727-STAT1. LN cells were harvested, rapidly fixed, and permeabilized. Cells were 
labeled for the markers indicated and analyzed using flow cytometry. Shown are blots representative of four independent experiments. (c) STAT1 and 
phospho-STAT1 analysis on Thps. Thps were purified using the aforementioned method and incubated in complete medium and culture conditions in 
absence (–) or presence of  TCR stimuli (TCR) or IFN- (+, 20 ng/ml). Shown are blots representative of three independent experiments.JEM VOL. 206, April 13, 2009 
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Recruitment to the IS and translocation to the nucleus  
of pS727-STAT1 upon Thp activation
To exert transcriptional regulation, STAT1 must translocate 
to the nucleus (36). The analysis of total STAT1 localization 
revealed very little nuclear translocation in Thps, even in the 
presence of activating stimuli (IFN­ or TCR ligation; Fig. 2 a). 
We hypothesized that the assessment of the localization of 
Thps from STAT1 mutants and deficient mice did not display 
any significant differences in IL­4. Although these robust levels 
of  Th1 differentiation were observed in C57BL/6­background 
Thps and might not be comparable to T cells from other 
strains, we can conclude that IFNGR1 and pS727­STAT1 sig­
naling accounts for at least half of the Th1 differentiation pro­
gram of  Thps in the absence of exogenous cytokines.
Figure 4.  Role of IFNGR and STAT1 during in vitro Th1 differentiation and pS727-STAT1 involvement in the IS. (a) CD4+CD62LhighCD25 Thps 
from wt or ifngr1/ mice were purified by magnetic bead separation, followed by flow cytometric sorting. Plate-bound anti-CD3 and anti-CD28 were 
used to activate cells, and after 5 d in culture the production of cytokines was evaluated by ICS and flow cytometry. Shown are results representative of 
six independent experiments. (b) Cells were sorted by negative selection of CD4+ T cells, activated by cross-linking of their TCRs, fixed, and stained as indi-
cated, and images were acquired and treated (deconvolution) as in Fig. 1 (of four experiments; n = 73–83). Bars, 2 µm.884 CYTOKINE RECEPTOR INCLUSION IN THE IMMUNOLOGICAL SYNAPSE | Maldonado et al.
IL4R corecruitment with the TCR in the absence of IFNGR1, 
STAT1, and NFATc2 and c3
We have shown that among several cytokine receptors, only 
IFNGR and, to a lesser extent, IL2R gain access to the IS. In­
terestingly, the IL4R remains in the periphery even in the pres­
ence of IL­4 or the complete absence of IFN­ (8). Because 
TCR­IFNGR1 corecruitment to the IS correlates with a Th1 
phenotype, it was possible that in Thp isolated from Th2­prone 
mice, the IL4R might similarly be recruited to the IS. We 
selected three genetic models of defective Th1 differentiation 
and pro­Th2 phenotype in vivo, IFNGR1­, STAT1­, and 
NFATc2– and c3–deficient mice (nfatc2/c3/) (34, 39, 40).
Fig. 6 a shows representative cells that were observed in 4 
independent experiments (88–114 cells per condition). At 
rest, cells from all genetic backgrounds display uniform distri­
butions of  TCR, IFNGR1, and IL4RA. Activation of  Thp 
STAT1 phosphoforms, which constitute only a fraction of 
STAT1, might provide a more accurate notion of its activity, 
as they represent a more terminal product of the signaling cas­
cade. Because the level of pY701­STAT1 expression is very 
low in Thps and not affected by TCR signaling (previous para­
graph), we focused on the behavior of pS727­STAT1.
The majority of resting Thps display uniform surface ar­
rangement of IFNGR1 and TCR (Fig. 4 b; 4 independent ex­
periments; n = 73–83). The distribution of pS727­STAT1 is 
similar in that its localization is dispersed across the cytoplasm, 
although some variability in the size and density of enriched 
foci can be observed. Our images showed no colocalization 
between the membrane­bound IFNGR1 (or TCR; unpub­
lished data) and pS727­STAT1 in resting Thps, suggesting no 
preassociation among these molecules. TCR­induced activa­
tion led to the redistribution and cocapping of IFNGR1 and 
TCR. Strikingly, pS727­STAT1 was redistributed to two ma­
jor sites, the IS and the nucleus (after 30 min of activation).
We quantified this recruitment by determining  values as 
in Fig. 3 (by whole­cell linearization of the cell surface) for the 
membrane­bound portions of pS727­STAT1, IFNGR1, and 
TCR (Fig. 5). Additionally, we performed a classical colocal­
ization analysis of pS727­STAT1 and nuclear staining to assess 
nuclear translocation. Results in Fig. 5 a show that, similar to 
STAT1, correlations between pS727­STAT1 and IFNGR1 
(pS727:IFNGR1), IFNGR1:TCR, and pS727:TCR distribu­
tions under resting conditions are weak, with only 0.05, 0.6, 
and 0.7% of cell sections scoring  ≥ 0.8 (double negative). 
This proportion markedly increased to 21, 25, and 30%, re­
spectively, of z sections above  ≥ 0.8 after Thp activation 
(double positive). To determine the degree of nuclear translo­
cation, regions containing the totality of each cell (per Z sec­
tion) were scanned for the presence of pS727­STAT1 and 
DAPI staining (Fig. S5). We used the Metamorph software to 
calculate the overlap of pS727­STAT1 and nuclear staining. 
At baseline, 25% of pS727­STAT1 molecules overlapped 
DAPI+ regions (Fig. 5 b). Activation of  T cells induced trans­
location of pS727­STAT1 to the nucleus and increased the 
amount of colocalization to 50%. This translocation was com­
parable to our positive control, in which cells were incubated 
in the presence of IFN­, a condition known to initiate STAT1 
shuttling to the nucleus.
IL-4 inhibits IFNGR1, STAT1, and pS727-STAT1 mobility 
after Thp activation
We have reported that IL­4 treatment of  Thp prevents associa­
tion of INFGR to the IS (8). As shown in Fig. 2, treatment with 
IL­4 also inhibits STAT1 recruitment, whereas the capping 
of the TCR was not affected. Quantification of cocapping by 
calculating  revealed poor correlation in the distribution of 
STAT1/IFNGR1 and TCR/IFNGR1 after incubation with 
IL­4 (Fig. 3 b). Similarly, pS727­STAT1 redistribution to the IS 
and nucleus was also impaired by IL­4 treatment and compara­
ble to resting conditions (Figs. 5 and 6). Thus, IL­4 signaling in­
hibits the mobilization of IFNGR1, STAT1, and pS727­STAT1 
toward the IS.
Figure 5.  Quantification of pS727-STAT1 localization. (a) Core-
cruitment assessment by whole-cell linearization method and correlation 
plots. As in Fig. 2, the distributions of the TCR, IFNGR1, and pS727-STAT1 
(pS727) were obtained by scanning the content of regions created around 
the surface and subjacent to the plasma membrane of every cell (n = 73–
83) for the calculation of  between the distribution of these markers. The 
correlation plots represent the pool of z sections (n = 1,980–2,490).  
(b) Translocation of pS727-STAT1 (pS727) to the nucleus. To obtain a nu-
merical value representing the degree of superposition between pS727-
STAT1 and DAPI stainings, a Metamorph built-in colocalization tool was 
applied to every cell by drawing regions that include the totality of each 
cell (membrane, cytoplasm, and nucleus). The results are expressed as the 
percentage of integrated surface of pS727-STAT1 that overlaps DAPI 
staining on a per cell basis (mean of all the z sections). The analysis herein 
combines observations of four independent experiments.JEM VOL. 206, April 13, 2009 
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IL­4, IgG1, and IgE and succumb to severe autoimmune al­
lergic and inflammatory conditions (39, 40). Thps from these 
mice exhibit constitutive differentiation to the Th2 subset 
even in the absence of IL­4, as indicated by the spontaneous 
Th2 differentiation of triple­deficient Thps (nfatc2/c3/il4/). 
This cytokine­independent pathway of Th2 differentiation 
mirrors the IFN­–independent Th1 differentiation we ob­
served in wt Thp, and hence offers an ideal system to com­
pare the behavior of these functionally opposing cytokine 
receptors. Thps were sorted from wt or nfatc2/c3/ mice, 
activated, and observed using the aforementioned method­
ology. We observed in two independent experiments (n = 
93–145; Fig. 7 a) that on Thps isolated from Th2­prone 
nfatc2/c3/ animals, the IL4R and the TCR colocalized and 
were almost completely superimposed after activation when 
led to the cocapping of the TCR and IFNGR1, regardless of 
the genetic background. In contrast, the distribution of IL4R 
changed depending on the integrity of the IFNGR–STAT1 
signaling pathway. In wt cells, IL4R is not a part of the IS. 
However, in ifngr1/ or stat1/ Thps, TCR activation re­
sults in corecruitment of  TCR and IL4R. Quantification of 
this phenomenon by the method of linearization and  calcu­
lation corroborated previous results and showed that in nor­
mal cells, TCR and IL4R distributions were poorly correlated, 
whereas in stat1/ and ifgnr1/ Thps, 33 and 20% of cells 
displayed  ≥ 0.8 (Fig. 6 b; mean of z sections per cell). Hence, 
in the absence of a pro­Th1 genetic background, the IL4R is 
actively recruited to the IS.
Mice lacking both the NFATc2 and NFATc3 transcrip­
tion factors (nfatc2/c3/) have very high levels of circulating 
Figure 6.  IL4R is recruited to the IS in the absence of IFNGR1 or STAT1. Thps were isolated by negative magnetic separation from the LNs of 
young animals of different genetic backgrounds (B6, ifngr1/, 129, and stat1/). CD4+CD62Lhigh T cells (98% pure) were activated, fixed, and stained as 
indicated, and then imaged as described in Fig. 1. (a) Confocal images. Bars, 4 µm. (b) Quantification by linearization of whole-cell surface. Four indepen-
dent experiments were analyzed, and the mean of  was calculated for each cell (n = 88–114), as in Fig. 2.886 CYTOKINE RECEPTOR INCLUSION IN THE IMMUNOLOGICAL SYNAPSE | Maldonado et al.
Th1-ness of naive Th cells
The  stimulus  responsible  for  the  very  earliest  induction  of 
IFN­ after Thp activation has remained elusive. Here, we 
suggest that this stimulus may be Thp activation itself, as TCR 
engagement  elicits  IFN­–independent  mobilization  of 
IFNGR, STAT1, and its posttranslationally modified isoform, 
pS727­STAT1 (8). Our studies show that in the absence of 
supplementary cytokines in vitro, Thps display a natural ten­
dency to differentiate along the Th1 pathway in an IFNGR­
dependent manner (Fig. 4). The Th1­ness of naive T cells 
might be explained by their remarkably high expression of 
STAT1 and pS727­STAT1 (Fig. 3) when compared with DP 
thymocytes or mature Th cells. S727­phosphorylated STAT1 
has been described as a primed monomeric form of STAT1 that 
may precede Y701­phosphorylation and is required for IFN­
/ and IFN­ biological responses (22, 38). More recent   
compared with the wt control. The quantification of these 
images confirmed the increase of  between TCR and IL4R 
distributions only in nfatc2/c3/ Thps after activation. This 
result extends the previous observations on naturally occur­
ring Th2­prone Thps (lacking IFNGR1 or STAT1) and pro­
vides another example of recruitment of the IL4R to the IS.
DISCUSSION
We have demonstrated that conditions promoting optimal Th1 
differentiation lead to corecruitment of STAT1, pS727­STAT1, 
TCR and IFNGR1 into the IS, and that this corecruitment is 
inhibited by Th2­inducing signals. The expression of high levels 
of STAT1 and pS727­STAT1 selectively in the progenitor Th 
cell may have arisen to guarantee “Th1 readiness” in the setting 
of microbial invasion. In cells with defective pro­Th1 signaling 
cascades, the opposing cytokine IL4R migrates to the IS.
Figure 7.  IL4R is recruited to the IS in the absence of NFATc2 and NFATc3. Thps were isolated prepared as in Fig. 1 from the LNs of young WT or NFATc2c3 
double-deficient mice. Thps were activated, fixed, and stained as indicated, and imaged as described in Fig. 1. (a) Confocal images. Bars, 4 µm. (b) Quantification by 
linearization of whole-cell surface. Two independent experiments were analyzed and the mean of  was calculated for each cell (n = 93–145), as in Fig. 2.JEM VOL. 206, April 13, 2009 
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ing an available pool of pS727­STAT1 to prime circulating Thp 
for rapid activation of STAT1­driven gene expression.
Cytokine receptor exclusion from the IS
IL4R–STAT6 signaling induces the exclusion of the IFNGR 
from T cell receptor–rich platforms (Figs. 1, 2, 4, and 5). Here, 
we provide evidence for functional consequences of this phe­
nomenon  by  showing  inhibition  of  STAT1  mobilization  to 
TCR/IFNGR­rich clusters in the presence of IL­4. Further, we 
demonstrate that the IL4R can gain access to the IS in cells with 
deficient Th differentiation (Figs. 7 and 8). Pathological situa­
tions where TCR and IL4R might colocalize exist. Individuals 
with inactivating mutations of IFNGR1 or STAT1 have a se­
verely impaired capacity (often lethal in children) to mount   
immune responses against intracellular pathogens, including my­
cobacteria and viruses (54–58). IFNGR down­regulation is gen­
erally observed in activated T cells and considered an essential 
mechanism of avoidance of antiproliferative and proapoptotic ef­
fects of IFN signaling (31, 59, 60). In patients with metastatic 
melanoma, i.v. administration of IFN­ leads to rapid induction 
of JAK/STAT inhibitors, which are the suppressor of cytokine 
signaling (SOCS) on PBMCs (61). Similarly, asthmatic patients 
have elevated expression of SOCS­3 in their peripheral CD3+ T 
cells, correlating with the severity of the disease. Further, in trans­
genic SOCS­3 mice, T cells are biased to the Th2 phenotype 
(62). Therefore, impairment of IFN signaling pathways by SOCS 
proteins may represent another condition in which IL4R and 
TCR may colocalize under physiological conditions. However, 
more experiments are required to test this hypothesis.
We are not aware of previous reports in lymphocytes where 
functional antagonists mutually regulate each other’s signaling 
potential by controlling receptor mobilization and hence acti­
vating capacity. Further, despite the large body of research on 
vertebrate JAK–STAT pathways, there is little precedent point­
ing toward polarized signaling. In a recent study, Sabatos et al. 
(63) identified polarization of phospho­STAT5 upon IL­2 para­
crine secretion among T cells. Along with our results, these data 
suggest that STAT signaling may generically operate in a polar­
izing fashion in T cells. In invertebrates, Sotillos et al. (64) re­
cently  found  that  preassembly  of  this  complex  to  discrete 
membrane domains primarily benefits signaling efficiency in 
Drosophila epithelial cells. In this same model, establishment of 
membrane asymmetry dictates unequal distribution of fate de­
terminants like Numb, Pon, and Neuralized, which are a funda­
mental mechanism underlying cell specification after asymmetrical 
cell division (65–69). T cells express the mammalian homo­
logues of the proteins involved in asymmetrical cell division 
(70–72) and have been shown to divide asymmetrically, a pro­
cess that determines their fate as effector or memory cells (12). 
Importantly, confirmation of IFNGR capping in the IS has been 
provided from these studies and suggests that daughter cells that 
are proximal to the IS retain IFNGR molecules. Therefore, 
these cells also retain IFN­ sensitivity and function as effectors 
by limiting bacterial burden in vivo (12). Further studies are re­
quired to evaluate whether this same principle can be applied to 
Th2 cells that fail to polarize their IFNGR during activation and 
studies have shown that STAT1 requires preassembly into chro­
matin­associated transcriptional complexes to become S727­
phosphorylated and fully biologically active in response to IFNs 
(41). However, these studies did not assess the phosphorylation 
status of STAT1 in different tissues, and especially Thps. Fur­
ther, other reports have shown that STAT1 can shuttle between 
the cytoplasm and nucleus independently of IFN stimulation 
and Y701 phosphorylation (42). Our observations are consis­
tent with a model in which STAT1 is “primed” in Thps and 
shuttles in and out of the nucleus and is retained during IFN or 
TCR signaling. Additional experiments are required to investi­
gate the expression of STAT1 at other stages of the differentia­
tion process (after activation and thymic maturation).
Cross talk between the TCR and IFNGR pathways
We have shown TCR, IFNGR, STAT1, and pS727­STAT1 
inclusion into the IS on naive Th cells (Figs. 1, 2, 4, and 5). 
Skrenta et al. have also observed some degree of physical associa­
tion of these receptors by showing IFN­–independent internal­
ization of IFNGR after TCR engagement (32), suggesting that 
these two pathways share signaling termination strategies. Cap­
ping and internalization of IFNGR seemingly occurs through 
the aggregation of lipid rich microdomains, a phenomenon that 
is also necessary for optimal TCR signaling and down­regulation 
(43, 44). STAT transcription factors, including STAT1, have also 
been shown to reside in lipid rafts (45, 46). Hence, there is evi­
dence that all components we have identified to confer “Th1­
ness” are localized in the same physical structure.
This physical association between the TCR and IFNGR 
pathways correlates with known pro­Th1 qualities of  T cell ac­
tivation. Serine phosphorylation of STAT1 is required for full 
STAT1 activity (21, 38) and plays an important role in linking 
signaling through these two receptors, as they both induce the 
activation of mitogen­activated protein kinase (MAPK) p38, 
which is the putative kinase upstream pS727­STAT1. Blockade 
of IFNGR or TCR signaling with PKC/PI3K or p38 MAPK 
inhibitors reduces STAT1­mediated gene transcription via the 
inhibition of this phosphoform (14, 17, 47, 48).
In contrast, our data indicate that naive circulating Th cells 
express pS727­STAT1 and that only IFNGR, but not TCR, 
signaling elicits a modest increase of this phosphoform. These 
differences may be explained by the choice of cell model used in 
our experiments; all cells were purified, freshly isolated T cells 
and not transformed cell lines. However, we cannot exclude the 
possibility that TCR signaling regulates pS727­STAT1 in vivo, 
resulting in saturating levels of pS727­STAT1 in Thp ex vivo 
that cannot be further increased. TCR “tickling” or in vivo 
nonproductive continuous TCR self­recognition by Thps is re­
quired for their survival (49). This low­affinity stimulus induces 
CD3 chain phosphorylation, involves NFB signaling (50), 
and may account for STAT1 serine phosphorylation. Another 
possible source of pS727­STAT1 in vivo is baseline cytokine 
signaling through IL7R (49, 51) and IL2R (that can directly 
interact with STAT1) (52). Both IL­2– and IL­7–induced T cell 
proliferation use p38 MAPK (53). Hence, the same mechanisms 
that control T cell homeostasis may also be responsible for ensur­888 CYTOKINE RECEPTOR INCLUSION IN THE IMMUNOLOGICAL SYNAPSE | Maldonado et al.
Concluding remarks
Establishment of membrane asymmetry plays an essential role 
the in acquisition of effector versus memory capacities of  T 
cells by unequal segregation of signaling molecules into daugh­
ter cells after cell division (12). Remarkably, this process is de­
pendent on and subsequent to antigen presentation and IS 
to determine whether both effector versus memory and Th cell 
differentiation are determined during synapse formation.
Huang et al. (73) found that ifngr1/ T cells have in­
creased  levels  of  STAT6  phosphorylation  and  association 
with the IL4R, providing evidence for the constitutive inhi­
bition of IL4R–STAT6 signaling by IFNGR. Zhu et al. (74) 
have also reported that constitutive STAT6 inhibition early 
during T cell activation and signaling through the IL2R, 
IL6R,  and  IFNAR  was  inhibited  by  TCR  engagement. 
These  authors  further  demonstrated  that  calcineurin  and 
PCK inhibitors known to decrease TCR­driven IFN­ pro­
duction increase STAT6 phosphorylation during TCR and 
IL4R signaling. However, the mechanisms underlying these 
intriguing  phenomena  have  remained  uncertain.  We  hy­
pothesize that receptor exclusion from the IS is mediated by 
sequestration of activating or inhibiting cofactors between 
IL­4 and IFNGRs (Fig. 8).
TCR signaling also intersects with IL4R signaling. TCR 
stimulation has been reported to activate the common  chain 
(c)–associated JAK3 (75). Our preliminary data show the pres­
ence of this important component for IL­2 and IL­4 signaling in 
the IS (Fig. S6). Additionally, cross talk between the JAK–STAT 
pathway, Erk, and PI3K has been demonstrated in Jurkat cells 
during IL­4 signaling. In this system, inhibition of Erk, PI3K, 
and Ras leads to inhibition of STAT6 activity (76). These obser­
vations suggest that IL4R and TCR signaling pathways compete 
for multiple components. These complexes often operate as 
multitasking platforms that result from the association of several 
molecules. Mobilization and sequestration of c–JAK3–STAT–
PI3K complexes could explain the inability of IL4R to enter the 
synapse and the transient inhibition of IL­4 signaling observed in 
Thp (74). Notably, we have shown partial IL2RA/TCR cocap­
ping during T cell activation, suggesting another level of com­
petition for c­JAK3 between the IL2R in the IS and the IL4R. 
A reciprocal mechanism of inhibitor exchange could be accom­
plished by a swap of SOCS proteins. socs1/ mice succumb to 
severe lymphopenia and multiorgan degenerative macrophage 
infiltration. Strikingly, double­deficient ifng/socs1/ mice 
survive up to a year, and socs1/ T cells display sustained IFN­
–IL­4 signaling with impaired IFN­ inhibition of IL­4 
production (77). In addition, TCR signaling controls SOCS1­
mediated cytokine signaling inhibition during positive selection 
of thymocytes (78). Both IFNGR and IL4R can bind SOCS 
proteins, thereby outcompeting JAK kinases. Exchanging adap­
tor molecules between receptors would allow mutual inhibition 
and restrict signaling to a single pro­Th cascade.
The observation that in nfatc2/c3/ Thp the IL4R enters 
the IS after TCR triggering is intriguing. NFATs are ex­
pressed early in T cell development (79) and regulate TCR­
mediated IL­4 gene transcription, and the absence of NFATc2 
and  NFATc3  leads  to  constitutive  nuclear  localization  of 
NFATc1 (40, 80). However, how these molecules modulate 
the arrangement of membrane receptors is unclear. NFATc2 
or NFATc3 regulate the expression of JAK2 that phosphory­
late STAT1, and thus affect its transactivation during IFNGR 
signaling (unpublished data).
Figure 8.  Model of receptor exclusion from the IS. (top) IFNGR, 
TCR, Stat, phospho-STAT1, JAK3, and eventually the common  chain (c) 
colocalize after TCR signaling. Under these conditions, inhibitors could 
mediate the exclusion of IL4R from the IS. (middle) IL-4 signaling blocks 
the recruitment of IFNGR, STAT1, and phospho-STAT1 to the TCR-rich 
regions of the membrane. This phenomenon could be mediated by asso-
ciation of inhibitors to the IFNGR and/or recruitment of c-JAK3 to the 
IL4R complex. Bottom panel. In the absence of pro-Th1 molecules, IFNGR, 
or STAT1, the IL4R is licensed to enter the IS to induce Th2 differentiation.JEM VOL. 206, April 13, 2009 
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The cytokines used, recombinant mouse IFN­ and IL­4, were ob­
tained from Peprotech.
Cell activation and staining for microscopy. Cells were activated in cell 
culture conditions (37°C, 5% CO2 in RPMI 10% FCS, nonessential amino ac­
ids, Hepes buffer, Penicillin, and Streptomycin) by cross­linking surface TCR 
with anti­TCR FITC or APC, followed by incubation with Alexa Fluor 488 
anti­FITC or Alexa Fluor 647–conjugated anti–hamster antibodies. After the 
indicated times, cells were washed twice with cold PBS and fixed with PBS 
0.5% PFA for 10 min at room temperature and stored in PBS 0.05% PFA at 
4°C. For surface staining, cells were washed twice with PBS and PBS­FCS 1% 
or PBS­BSA 2% (wash media) sequentially and stained in the same media. For 
intracellular staining, cells were washed twice with wash media and permeabi­
lized with PBS­FCS 2% supplemented with 0.05% Triton X­100. Cells were 
observed immediately after staining in Nunc coverslip microchambers by re­
suspending them in collagen matrixes (1 mg/ml; Vitrogen) to avoid shifting of 
the cells during observation. Microchambers were spun to allow cells to re­
main in the same plane of the collagen matrixes.
In vitro Th differentiation and intracellular cytokine staining (ICS). 
Purified Thps were cultured at 106/ml in 48­well plates (BD) coated with 
anti­CD3 (2c11) and anti­CD28 at 2 µg/ml. For Th0 conditions, cells were 
incubated with recombinant IL­2 (20 ng/ml; Peprotech). For Th1 condi­
tions, cells were incubated in the presence of anti–IL­4 antibody (10 µg/ml), 
IL­2, and IFN­ (20 ng/ml; Peprotech). For Th2 skewing, cells were incu­
bated in the presence of anti–IFN­ antibody (10 µg/ml) and IL­4 (20 ng/
ml; Peprotech). For ICS, cells were stimulated in Th0 conditions and re­
stimulated with PMA (50 ng/ml) and ionomycin (1 µM) for 2 h, and then 
monensin (3 µM final concentration) was added for another 2 h. Cells were 
harvested and washed in PBS. After fixation in 4% PFA at room temperature 
for 10 min, cells were washed once in PBS, once in PBS containing 1% FCS, 
and finally in staining buffer (PBS 1%, FCS 1%, and saponin). Cells were re­
suspended in staining buffer containing anti–IFN­ and anti–IL­4 FITC­
conjugated antibodies (BD) and incubated on ice for 25 min. Nonspecific 
staining was blocked with FcR blocking antibody (CD16/CD32). Cells 
were washed twice in staining buffer, and data were acquired using a FACS­
Calibur (BD).
Western blots. After the indicated treatments, cells were washed two times in 
PBS and lysed in the following buffer for protein extraction: 1% Triton X­100, 
50 mM Tris, pH 8.0, 100 mM NaCl, 50 mM NaF, 1 mM EDTA, phosphatase 
inhibitor cocktail (Sigma­Aldrich), and protease inhibitor cocktail (Roche). Ly­
sates were cleared by centrifugation for 10 min at 14,000 rpm. Western blotting 
was performed by probing with primary antibody, followed by horseradish per­
oxidase–conjugated goat anti–rabbit IgG (Zymed Laboratories) and enhanced 
chemiluminescence according to the manufacturer’s instructions (Thermo Fisher 
Scientific). Quantification was achieved by using ImageJ software from National 
Institutes of Health by assessing the integrated density of the blots. These results 
are shown in Fig. S3. These results were normalized to their respective HSP90 
control and displayed in Fig. 3 as the percentage relative to the highest density, 
as in this example: percentage of STAT1 relative to the highest density = (nor­
malized STAT1 density × 100/highest normalized density) where normalized 
STAT1 density = (STAT1 density – background density/individual HSP90 
density – background density).
Microscopy and image analysis. Images were acquired using two micros­
copy systems. An Axiovert 200 epifluorescence microscope (Carl Zeiss, Inc.) 
controlled by the aid of Metamorph software (Universal Imaging) and an X81 
epifluorescence microscope (Olympus) equipped with a Disk Scanning Unit 
(DSU) controlled by the aid of the IPLab software (Scanalytics). Images were 
taken using 100× objectives and software­deconvoluted using the Nearest 
Neighbors method for representation purposes (pictures in figures). The co­
capping and colocalization measurements were obtained by using Metamorph 
software. 30–40 optical sections were collected through each imaged cell in 1 
µm intervals using a piezoelectric z­positioner on the objectives.
formation, suggesting that in addition to controlling cell differ­
entiation into major Th subsets, the IS directs the establishment 
of  immunological  memory.  Exclusion  of  cytokine  receptors 
from the IS may represent a general mechanism of specific inhi­
bition by functionally opposing or competing signaling cascades 
similar to the mechanisms of cell polarity establishment men­
tioned above. We propose that the widely known inhibitory   
effect of IL­4 over pro­Th1 stimuli can be explained by the 
blockade of IFNGR and STAT1 mobilization. Reciprocally, 
the sole presence of IFNGR or STAT1 suffices to impede 
IL4R inclusion into the IS, and presumably its participation in 
the Th2 differentiation program. This latter result is particu­
larly relevant in physiological situations where levels of IF­
NGR or STAT1 are naturally low, such as in activated Th1 
(31) and Th2 cells (Fig. 3), respectively.
These observations suggest that similar to invertebrate cells, 
the fate and differentiation program of mammalian T cells is reg­
ulated through the organization of membrane topography and 
receptor mobilization, wherein inclusion or exclusion from 
compartmentalized supramolecular structures affects the integ­
rity of signaling cascades.
MATERIALS AND METHODS
Mice and cells. Mice of the following backgrounds were obtained from 
The Jackson Laboratory or Taconic Farms: C57/B6, 129s6/SvEv, BALB/c, 
ifngr1/, stat1/, and il4ra/. Ifnar1/ mice were provided by H. Cantor 
(Dana­Farber Cancer Institute, Boston, MA). Stat1-s272a mutants were pro­
vided by T. Decker (University of Vienna, Vienna, Austria). All mice were 
bred and maintained, and all animal experimentation was approved, in ac­
cordance with guidelines and approval of the Harvard University Institu­
tional Animal Care and Use Committee.
Naive Thps were isolated from single­cell suspensions of LNs and/or 
spleens of young mice of different genetic backgrounds and enriched using 
MACS magnetic negative selection (Miltenyi Biotec) with a cocktail of mi­
crobead­coupled antibodies directed against CD8, CD11b, CD11c, CD19, 
B220, DX5, MHCII, and TER119. Alternatively, cells were sorted using an 
automated RoboSep machine and an EasySep CD4+ T cell enrichment kit 
(StemCell Technologies). When indicated, cells were stained with anti­CD4 
APC­Alexa Fluor 750 (RM4­5; Invitrogen), CD25­PerCP (PC61; BD), 
and CD62L­APC monoclonal antibodies (MEL­14; BD) and subjected to 
further purification of CD4+CD25lowCD62Lhigh naive T cells using a FAC­
SAria system (BD). DPs were purified from thymic single­cell suspension by 
flow cytometry (see above) of CD4+CD8+CD11cCD11bDX5 DTCR 
B220CD19 cells.
Antibodies and reagents. Primary antibodies: FITC/APC­coupled ham­
ster  anti–mouse  TCR­  (H57;  BD  and  BioLegend),  FITC­coupled  rat 
anti–mouse IFNGR1 (GR20; R. Schreiber, Washington University School 
of Medicine, St. Louis, MO; conjugated in our laboratory), biotinylated 
hamster anti–mouse IFNGR1 (2E2; obtained from BD or R. Schreiber), 
PE­coupled rat anti–mouse IL4R (M1; BD), rabbit anti–mouse STAT1, 
rabbit anti–mouse phosphotyrosine 701­STAT1 (58D6), rabbit anti–mouse 
phosphor­serine727­STAT1  (all  from  Cell  Signaling  Technology).  Goat 
anti­JAK3 antibodies were directly conjugated to Alexa Fluor 647 in our 
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The linearization method used in an earlier study (8) to measure the degree 
of cocapping of different molecules was improved by extending the analysis of 
the cell surface over multiple z sections of the same cell population. Scans of the 
cell surface were made by drawing ring­shaped regions that included the mem­
brane and the subjacent cytoplasm for every focal z plane of cells.
For every pixel in these regions the intensity and position of each fluo­
rochrome is tabulated. Typically, for one cell, 100 pixels were scanned per 
single z section. Between 10 and 40 z sections were analyzed per cell on a 
total of 100 cells in different experiments. This method allows us to assess 
the degree of capping of different molecules as opposed to the simple colo­
calization method that does not account for their spatial distribution in the 
cell membrane. Correlation coefficients between the distributions of the flu­
orochromes were calculated as follows:
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x x y y
x x y y
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(http://mathworld.wolfram.com/CorrelationCoefficient.html). Subse­
quently, these values were represented as a correlation plot where the correla­
tion between the distributions of two given molecules is plotted against the 
correlation for two other molecules. This representation allows simultaneous 
visualization of the correlation for three different molecules for every focal z 
plane. Calculating the average of the correlations for every cell allowed us to 
obtain the correlation on a per cell basis. To calculate the colocalization of flu­
orochromes, images were thresholded (the background was subtracted) and 
analyzed using Metamorph built­in tools to calculate the integrative colocal­
ization index in percentages.
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delineating the contour of the cell over the TCR staining on the membrane and 
across the different optical planes acquired by confocal microscopy. These lines 
served to perform linescan of the area in close proximity. This technique is the 
fundament of the whole cell linearization of the cell surface method. Fig. S2 de­
picts correlation plots displaying the average of the correlation coefficients () on 
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and TCR on the y axis and TCR and IFNGR1. In Fig. S3, we show the raw 
quantification data of STAT1 and phospho­STAT1 on Thp and Th cells. Fig. 
S4 shows the critical negative control of immunoblot of protein extracts from 
stat1/ Thps. Fig. S5 shows the regions that were used to measure the overlap 
of pS727­STAT1 and nuclear (DAPI) staining. Fig. S6 shows the corecruitment 
of  TCR, IFNGR, and JAK3 to the IS. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20082900/DC1.
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